Loading…
Based on limited metadata, the FDA issued a Warning Letter to Coenzyme A, Inc. (also operating as Coenzyme-A Technologies, Inc.) on January 5, 2018, regarding an unspecified product category. Without access to the full letter text or subject line details, the specific nature of the regulatory violations cannot be determined from the available information. The issuing office is not identified in the metadata provided, limiting further context about the regulatory scope and product classification involved.